Stock Watch: How The Pandemic Impact On Pharma’s Value Chain Is Mutating
Emerging Challenges Threaten Manufacturing, Supply And Regulatory Decision-Making
Executive Summary
From clinical trials to in-person sales calls, the pharmaceutical value chain has been tested by the COVID-19 pandemic, but has held up. Nevertheless, recent friction within this chain may be more than a passing irritation.